Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology. (Q38105566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Rafael Guimarães dos Santos

series ordinal

1

1 reference

28 August 2017

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychoactive Drugs

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

68-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Health status of ayahuasca users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Fast and slow metabolizers of Hoasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Pharmacokinetics of Hoasca alkaloids in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Platelet serotonin uptake sites increased in drinkers of ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Ayahuasca in adolescence: a preliminary psychiatric assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Ayahuasca in adolescence: Qaualitative results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Ayahuasca in adolescence: a neuropsychological assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Report on psychoactive drug use among adolescents using ayahuasca within a religious context

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Assessment of addiction severity among ritual users of ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Effects of the Amazonian Psychoactive BeverageAyahuascaon Binocular Rivalry: Interhemispheric Switching or Interhemispheric Fusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

MDMA: on the translation from rodent to human dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Serotonin syndrome and drug combinations: focus on MAOI and RIMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

A species-specific difference in the effects of harmaline on the rodent olivocerebellar system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Maternal and developmental toxicity of ayahuasca in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Bringing ayahuasca to the clinical research laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Brain serotonin transporter binding in former users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Caveat emptor: editors beware

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Death following ingestion of MDMA (ecstasy) and moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Clinical pharmacology of MAO inhibitors: safety and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

Serotonin toxicity involving MDMA (ecstasy) and moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.763564

10.1080/02791072.2013.763564

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23662333%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference